Zhejiang Ausun Pharmaceutical Co., Ltd. (SHA:603229)
China · Delayed Price · Currency is CNY 9.85
-0.02 (-0.20%)
Jan 23, 2026, 3:00 PM CST
Zhejiang Ausun Pharmaceutical Company Description
Zhejiang Ausun Pharmaceutical Co., Ltd. engages in the research and development, process development, manufacture, and sale of APIs and pharmaceutical intermediates.
It offers fluorine products, prostaglandins, antimicrobials, and oncology products. The company also provides products for liver disease, respiratory system, and cardiac and cerebral vessels, as well as CNS indications.
In addition, it offers development and manufacturing services to the pharmaceutical, cosmetics, and nutritional industries.
The company was founded in 2010 and is based in Linhai, China.
Zhejiang Ausun Pharmaceutical Co., Ltd.
| Country | China |
| Founded | 2010 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 1,219 |
| CEO | Zhiguo Zheng |
Contact Details
Address: No. 5 Donghai Fourth Lane Linhai, 317016 China | |
| Phone | 86 576 8558 9335 |
| Website | ausunpharm.com |
Stock Details
| Ticker Symbol | 603229 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100002XK2 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Zhiguo Zheng | Chairman and GM |
| Shilan Zheng | Accounting Supervisor and Director |
| Huadong Zhang | Deputy GM and Director |
| Xiaochen Ying | Board Secretary |
| Ding Min Zhu | Chief Financial Officer |
| Kai Gao | Deputy General Manager |
| Yu Zhong | Deputy General Manager |